CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 4.8% to $4.78B in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.2%, from $4.89B to $4.78B.
Indicates the company's long-term investment horizon and exposure to interest rate cycles over the next decade.
This metric tracks the fair value of debt securities in the available-for-sale portfolio maturing between five and ten y...
Standard maturity profile disclosure for utilities with structured investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_2a379c| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.68B | $4.72B | $4.97B | $4.56B | $4.35B | $4.30B | $4.08B | $3.89B | $4.46B | $4.29B | $4.89B | $4.39B | $4.56B | $4.78B |
| QoQ Change | — | +0.8% | +5.2% | -8.2% | -4.7% | -1.1% | -5.1% | -4.6% | +14.7% | -3.9% | +14.0% | -10.3% | +4.1% | +4.8% |
| YoY Change | — | — | — | -2.6% | -7.9% | -13.4% | -10.6% | -10.5% | +3.8% | +5.1% | +25.7% | -1.7% | +6.4% | -2.2% |